Dr Reddys Laboratories receives USFDA nod for Pamidronate Disodium, which used to treat excessive ranges of calcium inside the blood.
According to media information, Dr Reddy’s and Intas Pharmaceuticals are in talks to collect Athenex Inc in a USD 2 hundred-250 million (Rs. 1580-1980 crore) deal, because the US-primarily based biotechnology firm seems to promote a controlling stake. Athenex is a clinical level biotech business enterprise and the acquisition, if gets thru may want to fortify DR Reddys presence within the biotech area.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
